Non‑trauma PTSD treatment for veterans and service members with mild or moderate TBI

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot tests a tailored non‑trauma intervention called T3 PTSD that provides individual psychotherapy sessions for veterans and active duty service members with mild or moderate TBI and comorbid PTSD. Twenty participants will be enrolled at Carl R Darnall Army Medical Center (Fort Hood, Texas) and receive the T3 PTSD intervention while standardized measures such as the Clinician‑Administered PTSD Scale (CAPS‑5) are used to track symptoms. The primary goals are to establish feasibility and acceptability of the approach, with secondary collection of symptom, functional, and safety outcomes before and after treatment. Eligible participants must be English‑speaking adults with TBI identified by the Ohio State University Brain Injury Identification Method and meet CAPS‑5 criteria for PTSD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Ability of participant to understand and the willingness to sign a written informed consent document based on interviewer assessment and clinical judgement.
2. Any veteran or active duty service member (age 18 or above) diagnosed with mild or moderate TBI as determined by the Ohio State University Brain Injury Identification Method
3. Participant meets diagnostic criteria for PTSD based on Clinician-Administered PTSD Scale (CAPS-5) interview as described by the National Center for PTSD which includes at least one Criterion B symptom, one Criterion C symptom, two Criterion D symptoms, and two Criterion E symptoms as well as meeting Criterions F and G.
4. Ability to read, write, and speak English based on interviewer assessment and clinical judgement.

Exclusion Criteria:

1. Participant is actively engaged in a behavioral intervention primarily targeting PTSD.
2. Participant has a psychiatric problem that warrants immediate treatment as indicated in the electronic health record, flagged during testing, or confirmed by a clinician through screening or review of clinical notes.
3. Participant demonstrates significant cognitive impairment that could impact treatment adherence/benefit based on interviewer assessment and clinical judgement.

Where it's running

• Carl R Darnall Army Medical Center
  Fort Hood, Texas, United States Recruiting

Study contacts

• Principal investigator: Cindy McGeary, PhD — The University of Texas Health Science Center at San Antonio
• Study coordinator: Cindy McGeary, PhD
• Email: mcgearyc@uthscsa.edu
• Phone: 210-567-5497

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

  This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

• Non-invasive vagus nerve stimulation (gammaCore) for PTSD

  This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.

  Recruiting Acacia Clinics · Sunnyvale, California · NCT07523685

• Bilateral cervical sympathetic blocks with optional integrative therapy for Special Operations veterans with PTSD and trauma-related symptoms

  This project will try bilateral cervical sympathetic blocks (BCSB), with or without added structured integrative therapy, to see if they reduce PTSD, TBI, and other trauma-related symptoms in Special Operations veterans.

  Recruiting Reset Medical and Wellness Center · Strongsville, Ohio · NCT07473505

• Psilocybin-assisted therapy for PTSD after sexual assault

  This trial will test whether a single 25 mg oral dose of psilocybin combined with therapy helps cisgender women who have PTSD from a sexual assault.

  Recruiting Phase 2 Sunstone Medical · Rockville, Maryland · NCT06902974

• Short-term therapy for PTSD symptoms

  This study is testing a week-long therapy to see if it can help adults with PTSD feel better and reduce their symptoms.

  Recruiting Ben-Gurion University of the Negev · Beersheba · NCT06826937

• Augmented reality-enhanced exposure therapy for PTSD in U.S. military personnel

  This tests whether adding augmented reality to standard exposure therapy helps U.S. military veterans and active-duty adults with PTSD.

  Recruiting Wayne State University · Charleston, South Carolina · NCT06740487

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.